New York --
IBM is teaming up with the New York Genome Center to help fight brain cancer.
The company said Wednesday that its Watson cloud computing system will be used in partnership with a genetic research center based in New York mainly to help sequence DNA for the treatment of glioblastoma, the most common type of brain cancer in U.S. adults.
New York Genome Center, a consortium of academic, medical and industry officials, will use Watson to sequence the DNA of cancer tumors at a much faster rate than would be possible if done by a human being. The DNA information would then be combined with clinical information and fed to Watson to help determine the best way to treat a particular patient.
Read more here: http://www.sfgate.com/technology/article/IBM-s-Watson-computer-joining-brain-cancer-battle-5332258.php